Journal scan

No clear evidence that most new cancer drugs extend or improve life

The majority of cancer drugs approved in Europe between 2009 and 2013 entered the market without clear evidence that they improved patient survival or quality of life, a new study suggests.
Author image
- @KatKeogh
Posted 16 October 2017 - 08:54
 
Jobs

Related articles

Adults born prematurely liable to more psychiatric problems

Adults born very prematurely experience higher rates of psychiatric symptoms than those who...
05 Feb 2018

The ‘mental health crisis’ in young people: real or contrived?

'A yawning generation gap has appeared in British society.'
06 Oct 2017

MRI scans shown to be effective in patients with first episode psychosis

A new study has provided evidence MRI scans can be an effective part of diagnosing First...
08 May 2017

Review launched to assess safety of type 2 diabetes medicines

A EU-wide review has been launched into medicines used to treat type 2 diabetes after more...
24 Jul 2015
5 Most Read Articles

From NHS nurse to lecturer: making the transition to education

What I’ve learned moving from an NHS role to academia, and the skills you need
11 Apr 2024

Pay reviews: what’s holding nursing back and what’s next after 20 years of AfC?

Unions are divided over the best way to overhaul Agenda for Change and boost retention
22 Apr 2024

Clinical placements survival guide: tips to help you cope with the shock of shift work

How to give yourself the best chance by eating well, requesting breaks and managing sleep
24 Apr 2024

How to be assertive in the workplace – and tips for getting the tone right

Advice on expressing yourself clearly while being respectful of patients and colleagues
23 Apr 2024

5 healthy meals tips: how to pack a lunchbox to look forward to on busy shifts

Time and money-saving advice on eating and drinking well while at work
09 Apr 2024
Journals
Other RCNi websites